Comparison of Extended-Release and Oral Naltrexone Assists Substance Abuse Treatment ProvidersDate: 5/4/2007
Media Contact: SAMHSA Press Office
Telephone: 240-276-2130
Oral naltrexone and naltrexone for extended-release injectable suspension are the focus of a new comparative report recently released by the Substance Abuse and Mental Health Services Administration (SAMHSA) in the Spring 2007 issue of Substance Abuse Treatment Advisory.
“Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence” (Substance Abuse Treatment Advisory, Spring 2007, Volume 6, Issue 1) (PDF)
______________________________________________________________________